Overview

Yubico provides strong two-factor authentication solutions through its main product, the YubiKey, a physical security key that requires users to insert or tap it for authentication. This method adds an extra layer of security beyond passwords, making it suitable for both personal and business use across various industries like finance and healthcare. Yubico differentiates itself by offering multiple YubiKey models tailored to different security needs and providing tools for developers to integrate YubiKey functionality into their applications. The company's goal is to continuously innovate and expand its product offerings to ensure robust security for its diverse clientele.

Simplify's Take

What believers are saying

• Growing demand for passwordless authentication boosts Yubico's market potential.
• YubiKey Bio Series addresses enterprise needs for phishing-resistant biometric security.
• Integration with Microsoft Entra ID enhances seamless onboarding for enterprise users.

What critics are saying

• Emerging side-channel attacks like EUCLEAK threaten YubiKey's microcontroller security.
• Adversarial AI could undermine Yubico's multi-factor authentication effectiveness.
• Reliance on traditional MFA methods may affect Yubico's market if not innovated.

What makes Yubico unique

• Yubico's YubiKey offers robust two-factor authentication with a physical security key.
• YubiKey is compatible with major platforms like Google, Microsoft, and Facebook.
• Yubico provides a range of hardware and software solutions for diverse industries.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$88.8M

Above

Industry Average

Funded Over

3 Rounds

Notable Investors:

Andreessen HorowitzNew Enterprise Associates

Notable Investors:

Andreessen HorowitzNew Enterprise Associates

$204,300,000

Post IPO Equity

Oct 2023

Post IPO Equity funding comparison data is currently unavailable. We're working to provide this information soon!

Post IPO Equity Funding Comparison

Coming Soon

View all funding stages